https://pf-06651600inhibitor.c....om/efficiency-regard
Of 196 cases with specimens and health records gathered from the 7 establishments, 88 operatively treated ones were analyzed regarding clinicopathological prognostic elements including CTNNB1 mutation standing. Excluding R2 instances (n=3), 5-year regional recurrence free survival (LRFS) was 52.9%. No situation had received pre- or post-operative radiotherapy. Univariate analysis revealed that extremity area (P less then 0.001) and larger dimensions (≧8cm, P=0.036) had been consider
Curtir
Comentario
Compartilhar
